Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages

Five to buy

Daily Mail and General Trust

(The Times) Shares in this sprawling media group have been buoyant recently amid optimism over the forthcoming flotation of Cazoo, the “hotshot online car dealer” in which DMGT holds a $1.35bn stake. The group’s exhibition business

is still weighed down by reopening uncertainty, but the outlook for the publishing side is brightening. Known for mid-market and freesheet newspapers such as the Daily Mail and Metro, the group is now moving into more specialist titles, recently acquiring New Scientist magazine for £70m. Such “knowledge-based and comment-heavy titles... may prove lucrative in the digital future”. A healthy balance sheet gives it the firepower to continue expanding. Risk- tolerant investors may want to get onboard. 866p

SmartSpace Software

(The Mail on Sunday) Research finds that over 80% of office workers want to continue working from home for at least part of the week. Businesses are also keen to promote the trend towards such “hybrid working”, given the potential cost savings from cutting back on office space. This IT- services group helps businesses digitalise services such as “desk management, meeting room bookings and visitor check-ins”. The group added 1,500 new accounts between March and June last year and growth has continued since. Although the company is currently loss- making, strong revenue growth should see it become profitable from next year. 145p

Pfizer

(Investors’ Chronicle) Despite the success of its vaccine, Pfizer’s share- price performance has underwhelmed over the past year. The Biden administration’s push to scrap Covid-19 vaccine patents may herald an era of tighter government regulation of the pharmaceutical industry. Pfizer was already facing a “patent cliff” in the middle of this decade as several key patents expire. But the gloom is overdone. The group’s emergence as a global leader in mRNA-technology opens the way to other therapies in the future, boosted by the Pfizer’s high spending on research and development. On just nine times 2022 earnings this could prove a “buying opportunity”. $40.12

Supreme

(Shares) Aim-listed Supreme licenses and distributes batteries and lighting products as well as serving the nutrition and vaping markets. Its in-house 88vape brand is the UK leader in vaping “e-liquids”. It also leverages  its “extensive retail distribution network” and design know- how to distribute products on behalf of other brands, including Duracell batteries and Panasonic. Business areas such as “nutrition and wellness” are experiencing strong growth, while the vaping market may be about to consolidate. On an “undemanding 14 times forecast earnings” and yielding a prospective 3.6%, this is a promising “growth and income play”. 188p

Redrow

(The Daily Telegraph) For all the talk of a housing bubble, ultra-low interest rates, ongoing government support and population growth should keep the market chipper for the foreseeable future. This housebuilder has reacted to changing demand among consumers, shifting

its activity out of London as digital working encourages many people to escape to the country. On a lowly forward price/earnings (p/e) ratio of ten the shares trade at a discount to other firms in the sector and offer a “margin of safety” if things go wrong. 680p

...and the rest

Shares

Ongoing demand for Covid-19 PCR tests and the global semiconductor shortage mean Aim-listed science-kit specialist SDI Group still has plenty of growth potential. Buy (175p). Mr Kipling-cakes owner Premier Foods is enjoying a strong recovery and could attract takeover interest. “Keep buying” (112p).

The Times

Energy supplier SSE is investing in the UK’s renewable future of offshore wind farms and is also exploring carbon-capture and hydrogen technologies. That leaves it well positioned, while the 5% dividend yield is a reward for waiting. Buy (1,540p). Denmark’s Rockwool produces insulation products by “heating volcanic rock until it is liquid and then spinning it into fine threads”. The resulting product is non-flammable, long-lasting and also provides sound insulation. The shares aren’t cheap but there will be massive demand in the coming years as Europe invests heavily in renovating buildings (DKr2,929).

Motley Fool

Theatres in the UK and US have reopened, but Cineworld’s shares are still down over the past year. Why? The problem is the debt pile, which “ballooned” during lockdowns to over eight times earnings before interest, tax, depreciation and amortisation (EBITDA). Ratios over two are seen as risky. Steer clear (92p).

The Mail on Sunday

Law firm Gateley’s focus on “mergers, acquisitions and property deals” seemed a lost cause when the pandemic began but the group has proved unexpectedly robust. This is an income stock with encouraging growth prospects (199p).

Recommended

UK inflation is at a 30-year high and it hasn’t peaked yet
Inflation

UK inflation is at a 30-year high and it hasn’t peaked yet

UK inflation has hit 5.4% - its highest in 30 years. And it could be heading higher. John Stepek explains what it means for you and your money.
19 Jan 2022
Index fund
Funds

Index fund

Index funds (also known as passive funds or "trackers") aim to track the performance of a particular index, such as the FTSE 100 or S&P 500.
18 Jan 2022
Model Y: Tesla has nailed it once again
Cars

Model Y: Tesla has nailed it once again

The electric carmaker’s new SUV crossover, the Model Y, sets the benchmark in the sector.
18 Jan 2022
The UK jobs market is booming – but wages are struggling to keep up with prices
UK Economy

The UK jobs market is booming – but wages are struggling to keep up with prices

Britain’s jobs market is booming, with wages rising and plenty of of vacancies. But inflation is rising faster than wages can keep up. John Stepek loo…
18 Jan 2022

Most Popular

Five unexpected events that could shock the markets in 2022
Stockmarkets

Five unexpected events that could shock the markets in 2022

Forget Covid-19 – it’s the unexpected twists that will rattle markets in 2022, says Matthew Lynn. Here are five possibilities
31 Dec 2021
US inflation is at its highest since 1982. Why aren’t markets panicking?
Inflation

US inflation is at its highest since 1982. Why aren’t markets panicking?

US inflation is at 7% – the last time it was this high interest rates were at 14%. But instead of panicking, markets just shrugged. John Stepek explai…
13 Jan 2022
Tech stocks teeter as US Treasury bond yields rise
Tech stocks

Tech stocks teeter as US Treasury bond yields rise

The realisation that central banks are about to tighten their monetary policies caused a sell-off in the tech-heavy Nasdaq stock index and the biggest…
14 Jan 2022